Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Influence of an interaction between lithium salts and a functional polymorphism in SLC1A2 on the history of illness in bipolar disorder.

Molecular diagnosis & therapy - 1 Oct 2012

Dallaspezia Sara, Poletti Sara, Lorenzi Cristina, Pirovano Adele, Colombo Cristina, Benedetti Francesco

Abstract excerpt

BACKGROUND: Bipolar disorder (BD) is a recurrent and disabling illness, characterized by periods of depression and mania. The history of the illness differs widely between patients, with episode frequency emerging as a strong predictor of poor illness outcome. Lithium salts are the first-choice l...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Bipolar Disorder
Share to Excitatory Amino Acid Transporter 2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene-Environment Interaction

Share to Homozygote

Share to Lithium

Share to Recurrence

Share to White People

Source

Identifiers

PMID: 23023733
DOI: 10.1007/s40291-012-0004-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23023733-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Influence of an interaction between lithium salts and a functional polymorphism in SLC1A2 on the history of illness in bipolar disorder.PMID 23023733Read ↗

A genomewide association study of response to lithium for prevention of recurrence in bipolar disorder.Semantic proximity Read ↗

Association of rare variation in the glutamate receptor gene SLC1A2 with susceptibility to bipolar disorder and schizophrenia.Semantic proximity Read ↗

Pharmacogenomics of Lithium Response in Bipolar DisorderSemantic proximity Read ↗

Lithium: a key to the genetics of bipolar disorderSemantic proximity Read ↗

Exploring lithium’s transcriptional mechanisms of action in bipolar disorder: a multi-step studySemantic proximity Read ↗

Molecular Signatures of Lithium Treatment: Current KnowledgeSemantic proximity Read ↗

The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia.Semantic proximity Read ↗

Lithium response in bipolar disorder: Genetics, genomics, and beyondSemantic proximity Read ↗

Association Study of the SLC1A2 (rs4354668), SLC6A9 (rs2486001) and SLC6A5 (rs2000959) Polymorphisms in Major Depressive DisorderSemantic proximity Read ↗

Variant GADL1 and response to lithium therapy in bipolar I disorder.Semantic proximity Read ↗

The Genetics of Response to and Side Effects of Lithium Treatment in Bipolar Disorder: Future Research PerspectivesSemantic proximity Read ↗

Pharmacogenetics of lithium effects on glomerular function in bipolar disorder patients under chronic lithium treatment: a pilot study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.